STAT

Opinion: Lullaby thoughts from a doctor dad on what the next 99 years of medical advances might bring for his son

It's hard to imagine what medical advances will take place during the next 99 years. As Dr. Seuss said, "Oh, the places you'll go."

For the past few years, I’ve been one of the caretakers of my 99-year-old father. A year ago, my wife and I joyfully added another person to our caretaking roles, our son Benjamin. As I tucked him in the other night, I started musing on the history and future of medicine. It turned into this letter.

Dear Benjamin,

A few weeks ago you turned one year old and Grandpa turned 99. It amazes me to imagine what medicine will have to offer you if you should live to age 99.

When Grandpa was your age, the world was in the midst of the so-called. Sir William Osler, the , had just died. And the world was still a decade from the , the first antibiotic.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks